Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RKDA
stocks logo

RKDA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.40M
+15.13%
-0.660
-77.93%
1.60M
+33.33%
-0.800
-142.11%
1.90M
+30.58%
-0.560
-82.82%
Estimates Revision
The market is revising No Change the revenue expectations for Arcadia Biosciences, Inc. (RKDA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 15.87%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+15.87%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA.O) is -1.47, compared to its 5-year average forward P/E of -1.71. For a more detailed relative valuation and DCF analysis to assess Arcadia Biosciences Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.71
Current PE
-1.47
Overvalued PE
-0.54
Undervalued PE
-2.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.17
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.20
Undervalued EV/EBITDA
-0.87

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.67
Current PS
0.00
Overvalued PS
3.46
Undervalued PS
-0.12
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

RKDA News & Events

Events Timeline

(ET)
2025-05-08
08:11:48
Arcadia Biosciences reports Q1 revenue $1.2M vs $987k last yea
select
2024-11-12 (ET)
2024-11-12
16:48:57
Arcadia Biosciences reports Q3 EPS ($1.18), consensus (81c)
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.5
12-04Newsfilter
Rigaku Launches XTRAIA MF-3400 for Semiconductor Measurement, Anticipates Over JPY 6 Billion Sales by 2026
  • Surging Market Demand: As generative AI and data centers expand, the semiconductor market's demand for high-performance, energy-efficient chips is skyrocketing, and Rigaku's launch of the XTRAIA MF-3400 will significantly enhance production efficiency to meet this trend.
  • Technological Innovation: The XTRAIA MF-3400 dramatically increases the number of wafers measurable per hour by doubling the X-ray dose and integrating a new transport system, enabling high-accuracy evaluation of complex semiconductor structures essential for mass production of next-generation memory chips.
  • Integrated Multifunctionality: This device incorporates three analytical functions—fluorescent X-rays, X-ray reflectance, and X-ray diffraction—allowing multiple measurements on a single device, which enhances production line flexibility and efficiency to cater to diverse manufacturing needs.
  • Future Prospects: Rigaku anticipates that combined with its predecessor, the XTRAIA MF-3400 will exceed JPY 6 billion in sales by FY2026, with plans for a sustainable growth rate of 20% in FY2027, showcasing strong application potential in new material and process fields.
[object Object]
Preview
9.5
11-10SeekingAlpha
Arcadia Biosciences Reports GAAP EPS of $0.63, Exceeding Estimates by $1.29; Revenue of $1.3M Falls Short by $0.1M

  • Earnings Performance: Arcadia Biosciences reported a Q3 GAAP EPS of $0.63, exceeding expectations by $1.29.

  • Revenue Trends: The company's revenue for the quarter was $1.3M, a 15.6% decrease year-over-year, missing estimates by $0.1M.

  • Zola® Growth: Year-to-date revenues for Zola® have increased by 26% compared to the previous year.

  • Financial Stability: Arcadia's gross profit margins have surpassed 30% for the 11th consecutive quarter, with a slight decline in cash balance to $1.1M.

[object Object]
Preview
7.0
10-09PRnewswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders

  • Investigation of Mergers: Halper Sadeh LLC is investigating potential violations of federal securities laws related to mergers involving Horizon Technology Finance Corporation, Arcadia Biosciences, Inc., and HNI Corporation.

  • Shareholder Rights: The firm encourages shareholders from these companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis with no upfront costs for clients.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Arcadia Biosciences Inc (RKDA) stock price today?

The current price of RKDA is 3.65 USD — it has decreased -0.27 % in the last trading day.

arrow icon

What is Arcadia Biosciences Inc (RKDA)'s business?

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

arrow icon

What is the price predicton of RKDA Stock?

Wall Street analysts forecast RKDA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKDA is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Arcadia Biosciences Inc (RKDA)'s revenue for the last quarter?

Arcadia Biosciences Inc revenue for the last quarter amounts to 1.30M USD, decreased -15.29 % YoY.

arrow icon

What is Arcadia Biosciences Inc (RKDA)'s earnings per share (EPS) for the last quarter?

Arcadia Biosciences Inc. EPS for the last quarter amounts to 0.62 USD, decreased -152.54 % YoY.

arrow icon

What changes have occurred in the market's expectations for Arcadia Biosciences Inc (RKDA)'s fundamentals?

The market is revising No Change the revenue expectations for Arcadia Biosciences, Inc. (RKDA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 15.87%.
arrow icon

How many employees does Arcadia Biosciences Inc (RKDA). have?

Arcadia Biosciences Inc (RKDA) has 9 emplpoyees as of December 05 2025.

arrow icon

What is Arcadia Biosciences Inc (RKDA) market cap?

Today RKDA has the market capitalization of 5.01M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free